This Article Full Text Full Text (PDF) All Versions of this Article: 148/8/4015    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prickett, T. C. R. Articles by Espiner, E. A. Search for Related Content PubMed PubMed Citation Articles by Prickett, T. C. R. Articles by Espiner, E. A. Pubmed/NCBI databases Gene Nucleotide Protein UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB UREA

C-Type Natriuretic Peptide Forms in the Ovine Fetal and Maternal Circulations: Evidence for Independent Regulation and Reciprocal Response to Undernutrition

Department of Medicine (T.C.R.P., T.G.Y., E.A.E.), Christchurch School of Medicine and Health Sciences, Christchurch 8015, New Zealand; and The Liggins Institute (C.W.H.R., A.J.B., F.H.B., J.E.H.), The University of Auckland, Auckland 1023, New Zealand

Address all correspondence and requests for reprints to: Timothy Prickett, Department of Medicine, Christchurch School of Medicine and Health Sciences, P.O. Box 4345, Christchurch 8015, New Zealand. E-mail: tim.prickett{at}chmeds.ac.nz.

C-type natriuretic peptide (CNP) has a crucial role in postnatal endochondral bone growth and is rapidly responsive to changes in nutrition. Although CNP is expressed in the placenta, little is known about the regulation and role of CNP in fetal-maternal health. We hypothesized that CNP may be similarly responsive to undernutrition in the growing fetus, in which maternal nutrition is crucial to normal growth and development. We therefore studied maternal and fetal CNP and the aminoterminal (bioinactive) fragment of proCNP (NTproCNP) in 39 chronically catheterized pregnant sheep before and after a 3-d maternal fast from 121 d gestation. Maternal CNP and NTproCNP levels were higher than in the fetus (CNP 12-fold, NTproCNP 1.5-fold, both P < 0.001). The ratio of NTproCNP to CNP was higher in the fetus than the mother (53 ± 3 vs. 8.7 ± 0.6, P < 0.001), suggesting enhanced synthesis and/or degradation of CNP in the fetus. As in postnatal lambs, fetal plasma CNP forms fell promptly during maternal fasting. In contrast, maternal levels exhibited reciprocal and contemporaneous increase, which was reversed by refeeding. Uteroplacental production of CNP was suggested by a high venoarterial concentration gradient across the gravid uterus, and a correlation between maternal NTproCNP levels and placental weight (r² = 0.26, P = 0.01). These studies provide the first evidence that CNP is regulated independently in the fetus. Reciprocal increases in maternal CNP forms may reflect the response of the uteroplacental unit to substrate deficiency. CNP may have a role in maintaining fetal welfare and provides a possible marker of uteroplacental nutrient supply.

This article has been cited by other articles:

				T. C. R. Prickett, B. Dixon, C. Frampton, T. G. Yandle, A. M. Richards, E. A. Espiner, and B. A. Darlow Plasma Amino-Terminal Pro C-Type Natriuretic Peptide in the Neonate: Relation to Gestational Age and Postnatal Linear Growth J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 225 - 232. [Abstract] [Full Text] [PDF]